FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2588406503> ?p ?o ?g. }

• W2588406503 endingPage "376" @default.
• W2588406503 startingPage "355" @default.
• W2588406503 abstract "The aim of our study was to systematically review the growing body of published literature reporting on one specific multiple sclerosis (MS) treatment, fingolimod, in the real world to assess its effectiveness in patients with MS, evaluate methodologies used to investigate MS in clinical practice, and describe the evidence gaps for MS as exemplified by fingolimod. We conducted a PRISMA-compliant systematic review of the literature (cut-off date: 4 March 2016). Published papers reporting real-world data for fingolimod with regard to clinical outcomes, persistence, adherence, healthcare costs, healthcare resource use, treatment patterns, and patient-reported outcomes that met all the eligibility criteria were included for data extraction and quality assessment. Based on 34 included studies, this analysis found that fingolimod treatment improved outcomes compared to the period before treatment initiation and was more effective than interferons or glatiramer acetate. However, among studies comparing fingolimod with natalizumab, overall trends were inconsistent: some reported natalizumab to be more effective than fingolimod and others reported similar effectiveness for natalizumab and fingolimod. These studies illustrate the challenges of investigating MS in the real world, including the subjectivity in evaluating some clinical outcomes and the heterogeneity of methodologies used and patient populations investigated, which limit comparisons across studies. Gaps in available real-world evidence for MS are also highlighted, including those relating to patient-reported outcomes, combined clinical outcomes (to measure overall treatment effectiveness), and healthcare costs/resource use. The included studies provide good evidence of the real-world effectiveness of fingolimod and highlight the diversity of methodologies used to assess treatment benefit in clinical practice. Future studies could address the evidence gaps found in the literature and the challenges associated with researching MS when designing real-world studies, assessing data, and comparing evidence across studies." @default.
• W2588406503 created "2017-02-24" @default.
• W2588406503 creator A5006343512 @default.
• W2588406503 creator A5015408835 @default.
• W2588406503 creator A5086492245 @default.
• W2588406503 creator A5089131482 @default.
• W2588406503 date "2017-04-01" @default.
• W2588406503 modified "2023-10-17" @default.
• W2588406503 title "Multiple sclerosis in the real world: A systematic review of fingolimod as a case study" @default.
• W2588406503 cites W1563482990 @default.
• W2588406503 cites W1565809790 @default.
• W2588406503 cites W1616161657 @default.
• W2588406503 cites W1803778850 @default.
• W2588406503 cites W1893794029 @default.
• W2588406503 cites W1964464603 @default.
• W2588406503 cites W1982508920 @default.
• W2588406503 cites W1984705645 @default.
• W2588406503 cites W1997159649 @default.
• W2588406503 cites W2000175930 @default.
• W2588406503 cites W2006479391 @default.
• W2588406503 cites W2014094373 @default.
• W2588406503 cites W2017715038 @default.
• W2588406503 cites W2024600931 @default.
• W2588406503 cites W2036193982 @default.
• W2588406503 cites W2043003871 @default.
• W2588406503 cites W2067338532 @default.
• W2588406503 cites W2072173083 @default.
• W2588406503 cites W2074754594 @default.
• W2588406503 cites W2081483570 @default.
• W2588406503 cites W2082301205 @default.
• W2588406503 cites W2087804398 @default.
• W2588406503 cites W2094998560 @default.
• W2588406503 cites W2102614462 @default.
• W2588406503 cites W2104948944 @default.
• W2588406503 cites W2118735809 @default.
• W2588406503 cites W2123870007 @default.
• W2588406503 cites W2124231203 @default.
• W2588406503 cites W2129183615 @default.
• W2588406503 cites W2138992948 @default.
• W2588406503 cites W2144095014 @default.
• W2588406503 cites W2149933470 @default.
• W2588406503 cites W2151340435 @default.
• W2588406503 cites W2159411766 @default.
• W2588406503 cites W2159561148 @default.
• W2588406503 cites W2159712156 @default.
• W2588406503 cites W2160215204 @default.
• W2588406503 cites W2173662187 @default.
• W2588406503 cites W2193056371 @default.
• W2588406503 cites W2194006053 @default.
• W2588406503 cites W2196420394 @default.
• W2588406503 cites W2222225656 @default.
• W2588406503 cites W2235417077 @default.
• W2588406503 cites W2274125150 @default.
• W2588406503 cites W2300277733 @default.
• W2588406503 cites W2331724298 @default.
• W2588406503 cites W2412766091 @default.
• W2588406503 cites W2484549831 @default.
• W2588406503 cites W2488549833 @default.
• W2588406503 cites W2489222638 @default.
• W2588406503 cites W583042304 @default.
• W2588406503 cites W937088433 @default.
• W2588406503 doi "https://doi.org/10.1016/j.autrev.2017.02.007" @default.
• W2588406503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28212923" @default.
• W2588406503 hasPublicationYear "2017" @default.
• W2588406503 type Work @default.
• W2588406503 sameAs 2588406503 @default.
• W2588406503 citedByCount "49" @default.
• W2588406503 countsByYear W25884065032017 @default.
• W2588406503 countsByYear W25884065032018 @default.
• W2588406503 countsByYear W25884065032019 @default.
• W2588406503 countsByYear W25884065032020 @default.
• W2588406503 countsByYear W25884065032021 @default.
• W2588406503 countsByYear W25884065032022 @default.
• W2588406503 countsByYear W25884065032023 @default.
• W2588406503 crossrefType "journal-article" @default.
• W2588406503 hasAuthorship W2588406503A5006343512 @default.
• W2588406503 hasAuthorship W2588406503A5015408835 @default.
• W2588406503 hasAuthorship W2588406503A5086492245 @default.
• W2588406503 hasAuthorship W2588406503A5089131482 @default.
• W2588406503 hasBestOaLocation W25884065031 @default.
• W2588406503 hasConcept C118552586 @default.
• W2588406503 hasConcept C160735492 @default.
• W2588406503 hasConcept C162324750 @default.
• W2588406503 hasConcept C17744445 @default.
• W2588406503 hasConcept C177713679 @default.
• W2588406503 hasConcept C189708586 @default.
• W2588406503 hasConcept C199539241 @default.
• W2588406503 hasConcept C2776036978 @default.
• W2588406503 hasConcept C2778577042 @default.
• W2588406503 hasConcept C2779473830 @default.
• W2588406503 hasConcept C2780640218 @default.
• W2588406503 hasConcept C2781004633 @default.
• W2588406503 hasConcept C50522688 @default.
• W2588406503 hasConcept C71924100 @default.
• W2588406503 hasConceptScore W2588406503C118552586 @default.
• W2588406503 hasConceptScore W2588406503C160735492 @default.
• W2588406503 hasConceptScore W2588406503C162324750 @default.
• W2588406503 hasConceptScore W2588406503C17744445 @default.

• next